The Blood transfusion Genomics Consortium (BGC) is an international partnership between blood services, research institutions and industry leaders.Our aim is to improve the safety and efficiency of blood and platelet transfusion by introducing cutting-edge genomics technology into routine clinical practice.As the part of the BGC, the national blood services of Australia, Canada, England, Finland, the Netherlands, and South Africa together with the New York Blood Center work in partnership with academic hospitals in Boston and Cambridge, and Thermo Fisher Scientific to develop the DNA-based assays, software solutions, and infrastructure required to implement donor and patient genotyping at global scale.https://bgc.io/